[LGND] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -67.74%
YoY- 1,112.89%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 21,619 17,701 14,973 13,005 6,375 5,741 7,802 18.49%
PBT 804 7,284 901 2,025 -52 -3,884 -11,436 -
Tax 160 -217,255 124 60 142 22 419 -14.81%
NP 644 199,165 1,280 1,965 -194 -3,906 -11,843 -
Tax Rate -19.90% 2,982.63% -13.76% -2.96% - - - -
Total Cost 20,975 -181,464 13,693 11,040 6,569 9,647 19,645 1.09%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 2.98 1,125.16 8.55 15.11 -3.04 -68.04 -151.79 -
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS 0.03 10.01 0.06 0.10 -0.01 -0.20 -0.60 -
EPS Diluted 0.03 9.28 0.06 0.09 -0.01 -0.20 -0.60 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.